1. Service Overview & Global Regulatory Compliance Framework
Our end-to-end bioprocessing plant design and construction delivers fully integrated one-stop turnkey solutions covering every stage from initial project consultation through design, equipment supply, construction, commissioning and final GMP qualification handover. All engineering outputs adhere rigorously to NMPA GMP, FDA cGMP, EMA Annex 1, PIC/S and ICH Q8/Q9/Q10 international quality standards, catering to full-spectrum biomanufacturing scenarios including monoclonal antibodies, ADCs, recombinant proteins, viral vaccines, microbial fermentation products and clinical trial pilot facilities. Unlike segmented service providers who split design, fabrication and construction into isolated phases, our unified delivery model eliminates information gaps, inconsistent technical specifications and repeated cross-party communication delays. The integrated service resolves prevalent industry pain points such as mismatched process-facility layouts, non-compliant cleanroom construction, disjointed equipment linkage and prolonged audit preparation cycles, delivering fully operational, inspection-ready bioprocessing campuses for both greenfield blank-site developments and brownfield facility retrofits.
2. Core Execution Philosophy & End-to-End Integrated Advantages
Guided by risk-based quality management and process-deterministic engineering principles, our full-cycle delivery anchors all layout and construction decisions to product-specific critical process parameters (CPPs) and critical quality attributes (CQAs). Comprehensive FMEA hazard assessment is embedded in the earliest conceptual design phase to identify and mitigate contamination risks, utility failure hazards and cross-product interference before construction commences, avoiding expensive post-completion rectifications. We vertically integrate bioprocess technical design, in-house sanitary stainless steel equipment manufacturing, standardized cleanroom construction teams and dedicated validation specialists under one unified management system. In contrast to fragmented multi-supplier collaboration, the end-to-end model synchronizes design logic, equipment sanitary standards, construction workmanship and automation control architecture, minimizing manual material transfer links, shortening total project lead time, lowering overall capital expenditure and guaranteeing consistent production reproducibility throughout facility operation.
3. Four Interconnected Core Functional Modules & Standard Deliverables
The complete end-to-end bioprocess plant delivery system consists of four sequential, mutually coordinated core modules covering the full project lifecycle: pre-project consulting & customized design, regulated equipment manufacturing & procurement, GMP-grade construction implementation, and system commissioning & compliance qualification.
1.Consulting & Design Module: Conducts site feasibility analysis, master campus zoning, BIM 3D process layout design, Grade A/B/C/D cleanroom planning, sanitary pipeline routing and utility system configuration, and generates complete DQ design documents and contamination control strategies aligned with global regulatory codes.
2.Equipment Manufacturing & Procurement Module: Produces tailor-sized bioreactors, media preparation tanks, purification skids and sterile storage vessels using 316L sanitary stainless steel; oversees vendor qualification, unified FAT testing and full material traceability documentation for all bioprocess hardware.
3.GMP Construction Module: Executes classified cleanroom enclosure installation, automatic orbital welding of dead-angle-free process piping, HVAC purification assembly and full MEP utility construction, with round-the-clock on-site quality supervision to eliminate non-compliant construction defects.
4.Commissioning & Qualification Module: Carries out cross-equipment linkage SAT testing, full-system process simulation, and delivers standardized IQ/OQ/PQ validation archives, risk assessment reports and customized SOP manuals to achieve full regulatory compliance handover.
4. Industrial Application & Full Lifecycle Post-Delivery Support
This end-to-end bioprocess plant solution applies extensively to large-scale commercial biologic greenfield factories, outdated biomanufacturing workshop compliance upgrades, small-scale biotech clinical pilot lines and multi-product flexible bioproduction parks. All plant designs adopt forward-looking modular architecture, reserving standardized expansion interfaces for future high-titer cell culture optimization, new biotherapeutic pipeline introduction and capacity expansion without large-scale structural demolition or reconstruction. We provide continuous long-term post-handover technical support including multi-language GMP operation training, periodic facility risk re-evaluation, equipment maintenance guidance and iterative bioprocess optimization consulting. As a single-source full-cycle delivery partner, we assist biopharmaceutical clients worldwide in controlling project cost and schedule risks, accelerating regulatory inspection clearance, and building resilient, efficient and internationally compliant modern bioprocessing manufacturing infrastructure.
